Dr Nathan Kerr was an invited speaker and moderator of the symposium on “New Advances in Minimally-Invasive Glaucoma Surgery” at the Asia Pacific Glaucoma Congress in Busan Korea in April.

At the conference, Dr Kerr delivered a presentation to over 500 ophthalmologists on “A New Era in Glaucoma Surgery with Supraciliary Stenting”, focusing on:

  • Advantages of the uveoscleral outflow pathway, a natural drainage channel that is the target of the most effective glaucoma eye drops, which can now be accessed in a minimally invasive procedure
  • Limitations of medical treatment and traditional glaucoma surgery
  • Use of the CyPass Micro-Stent in mild to moderate open angle glaucoma to reduce eye pressure and need for glaucoma medications